Sixth Community Pharmacy Agreement (6CPA)

Evaluation of the 6CPA community pharmacy programs

6CPA program changes from 1 July 2017

The Government will provide $825 million over three years, from 2017-18, to community pharmacies to support and improve Australians’ access to medicines, under the Improving Access to Medicines – support for community pharmacies measure. This includes $600 million through the Sixth Community Pharmacy Agreement (6CPA) to continue existing community pharmacy programs and enable pharmacists to deliver new and expanded medication management services for Australians who need additional assistance to manage their medications.

The following pharmacy programs have been redesigned to support the collection of information to assist with assessment of the effectiveness of these services.

  • Dose administration aids
  • Staged supply
  • MedsChecks
  • Diabetes MedsChecks
  • Home medicines review program
  • Pharmacy trial program

All other 6CPA Programs will continue from 1 July 2017 in their current format pending the outcomes of program assessments/evaluations.

Read more about program changes (PDF, 252.99 KB)

Sixth Community Pharmacy Agreement

The Sixth Community Pharmacy Agreement (6CPA) was signed on 25 May 2015 to take effect from 1 July 2015.

Sixth Community Pharmacy Agreement (PDF, 752.16 KB)

Key features of the 6CPA include:

  • Dispensing remuneration indexed to the Consumer Price Index
  • An increased investment in community pharmacy programs and services
  • A Government commitment to extend the Location Rules until mid-2020, with an independent review to be conducted during the 6CPA to inform future arrangements.

Visit the 6CPA website to find out more.

The following resources provide further information about components of the 6CPA and related matters:

A new Administration, Handling and Infrastructure (AHI) Fee, which replaces the previous pharmacy mark-up.

Was this page useful to you?

Page last updated 27 August 2019